Tata Elxsi Q2 FY26 Earnings Presentation and Fact Sheet

Tata Elxsi reported operating revenue of ₹918.1 crores for Q2 FY26, a 2.9% increase QoQ. Profit Before Tax rose by 9.4% QoQ to ₹214.7 crores. The Media & Communication business saw a 6.8% QoQ growth, while the Transportation business grew by 0.7% QoQ. The company also inaugurated a Global Technology Centre for Medical Devices for Bayer.

Financial Highlights

In the second quarter of FY26, Tata Elxsi’s operating revenue reached ₹918.1 crores, marking a 2.9% growth compared to the previous quarter. However, there was a -3.9% decrease Year-over-Year (YoY). Profit Before Tax (PBT) increased significantly by 9.4% QoQ, reaching ₹214.7 crores.

Key financial figures include:

  • EBITDA Margin: 21.1%
  • PBT Margin: 22.2%
  • Profit After Tax (PAT): ₹154.8 Cr, a 7.2% QoQ increase

Segment Performance

Performance varied across different business segments:

  • Transportation: Revenue grew by 0.7% QoQ.
  • Media and Communications: Revenue increased by 6.8% QoQ.
  • Healthcare: Revenue saw a decline of 2.3% QoQ.

Geographical Performance

The company saw strong growth across overseas markets, especially in the United States, where growth reached 7.9% QoQ.

Key Deals and Partnerships

Tata Elxsi has secured several key deals and partnerships during the quarter:

  • Established a Cloud HIL Center for Suzuki Motors in India.
  • Launched a Global Technology Centre for Medical Devices with Bayer in Radiology.
  • Won a multi-year deal with a Japan Headquartered OEM for advanced system design and simulation.
  • Secured a digital transformation deal with a US Headquartered Media Leader.
  • Partnered with Synopsys to accelerate SDV development through Virtualization.

Recognitions

Tata Elxsi was recognized by Dell Technologies with the ‘ISG Field Support Partner of the Year’ Award.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!